Stories

Health Minister Dzulkefly Ahmad is preparing a report for the Cabinet on the timing and process of imposing a potential vape ban to prevent legal challenges. The government currently refrains from banning vapes and e-cigarettes to avoid complications after legally registering and regulating the industry under Act 852. Dzulkefly noted that a sudden ban could lead to legal issues due to the expectation set by the existing regulations. While considering a complete ban, factors like legal implications, enforcement, and public health are being evaluated. Some states have already prohibited vape sales.

Experts criticized a Daily Mail article labeling vapes as harmful to youth as misleading. The research cited lacks evidence of causation, purposefully excludes benefits, and relies on low-quality data. The umbrella review of reviews on youth vaping connected it to smoking and health issues but didn't prove causation. Claims of vaping leading to smoking were disputed, with smoking rates among youth decreasing as vaping rose. Concerns about asthma effects were uncertain. The EVALI outbreak was linked to illicit THC, not nicotine e-liquids. Experts suggest caution with youth vaping while avoiding broad conclusions about adult harm reduction based on this limited review. Media misrepresentation undermines harm reduction efforts.

The text discusses academia's issues with biased research on nicotine/tobacco due to funding pressures and incentives that prioritize grant funding over quality. The system is unsustainable, favoring quantity over quality in publications and research that aligns with funding agency priorities. Pressure to secure NIH grants leads researchers to conform to agency views, hindering unbiased research. The oversaturation of PhDs exacerbates competition for academic positions, perpetuating a cycle of grant dependence. The focus on grant funding also compromises teaching quality and hampers diverse research perspectives. Future posts will explore solutions to address these systemic challenges in academia.

ActionSA MP Dr. Letlape defended vaping against Health Department claims, stating it's less harmful than smoking. He criticized false radio ads equating vaping to smoking and accused the department of spreading propaganda. Letlape lodged a complaint and called for the ads' withdrawal, arguing they mislead the public and undermine Parliament's authority. Letlape urged Health Minister Motsoaledi to clarify the misinformation and emphasized vaping's potential for smoking cessation. While e-cigarettes are deemed less harmful by Cancer Research UK, they are not risk-free and should only be used for smoking cessation. The Health Department's misleading ads are criticized for interfering with legislative processes.

In this episode of GFN Voices, Gabriel Oke explores one of the most overlooked yet vital aspects of scientific work: communication. He explains that no matter how important or innovative research may be, its true impact depends on how clearly and effectively it is shared with the world. From researchers and academics to policymakers, advocates, and the public, communication is the bridge that turns data into action and science into progress.

Daily Pouch Money reviews nicotine pouch makers. PMI rose 7.3% and BAT 20%. Analysts explore Altria, up 23.6%, predicting its future amid smoke-free ambitions and regulatory risks. Altria’s on! pouches surge 18%, aiming for $5 billion yearly by 2028. Market share decline suggests Marlboro loyalty. Despite downsides like US regulation and stiff competition, Altria's dividends and potential gains from NJOY vapes provide buying incentives. Investing in Altria balances risk and reward, and while short-term projections are positive, long-term growth may be modest due to industry shifts. Ultimately, Altria's performance depends on innovation and market dynamics, setting expectations for single-digit growth in 2025.

Australia's tough anti-vaping laws face international challenges, per a UTS-Monash University paper. Health risks from vaping, especially among youth, prompt restrictions. With a history of industry litigations, policy decisions must align with global trade rules. Proving public health benefits is crucial to weather potential legal challenges. Transparency and ongoing justification are key. Australia must defend its laws before the WTO and set a precedent like the tobacco plain packaging. Researchers advocate for evidence-based justifications to uphold regulations. Success in reducing vaping harms could pave the way for global policy standards and protect public health internationally.

Vaping among young people significantly increases the likelihood of future smoking, asthma, cough, injuries, and mental health issues. Research shows a concerning link between vaping and harmful behaviors, prompting calls for stricter regulations. While evidence is largely observational, studies indicate a threefold increase in smoking initiation among young vapers. Asthma risk rises by 20-36%. The relationship between vaping and smoking urges governments to act swiftly. Despite vaping being a less harmful alternative for adults, it poses serious risks for youth. Controversy exists on the causality of vaping leading to smoking. Urgent actions are needed to protect children from the dangers associated with vaping.

The FDA portrays itself as protecting Americans from dangerous products, but its history suggests otherwise. Its approval of opioids helped cause the deadly epidemic that has killed hundreds of thousands since 2000. At the same time, the FDA restricts safer alternatives to cigarettes, applying stricter standards to harm-reduction products while effectively protecting cigarette companies. Although the dangers of smoking have been known since the 1960s, the 2009 Tobacco Control Act gave the FDA broad authority over nicotine products, requiring new ones to undergo a burdensome approval process to prove they benefit public health.

In this special reaction episode, we break down a powerful moment from The Pack Breakers podcast when a South African MP boldly questioned the influence of foreign-funded NGOs and international institutions like the WHO in shaping South Africa’s tobacco control legislation.